Literature DB >> 22144282

Use of phage display for the identification of molecular sensors specific for activated Rho.

Patrick Chinestra1, Isabelle Lajoie-Mazenc, Jean-Charles Faye, Gilles Favre.   

Abstract

We describe a phage display approach to select active Rho-specific scFv sensors. This in vitro technique allows preserving the antigen conformation stability all along the selection process. We used the GTP locked RhoBQ63L mutant as antigen against the Griffin.1 library composed of a human synthetic V(H) + V(L) scFv cloned in the pHEN2 phagemid vector. The method described here has permitted to identify an scFv that discriminates between the activated and the inactivated form of the Rho subfamily.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22144282     DOI: 10.1007/978-1-61779-442-1_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

Review 1.  Antibody phage display libraries: contributions to oncology.

Authors:  Carmela Dantas-Barbosa; Marcelo De Macedo Brigido; Andrea Queiroz Maranhao
Journal:  Int J Mol Sci       Date:  2012-05-04       Impact factor: 6.208

2.  Generation of a single chain antibody variable fragment (scFv) to sense selectively RhoB activation.

Authors:  Patrick Chinestra; Aurélien Olichon; Claire Medale-Giamarchi; Isabelle Lajoie-Mazenc; Rémi Gence; Cyril Inard; Laetitia Ligat; Jean-Charles Faye; Gilles Favre
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

3.  NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies.

Authors:  Sandrine Moutel; Nicolas Bery; Virginie Bernard; Laura Keller; Emilie Lemesre; Ario de Marco; Laetitia Ligat; Jean-Christophe Rain; Gilles Favre; Aurélien Olichon; Franck Perez
Journal:  Elife       Date:  2016-07-19       Impact factor: 8.140

4.  Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line.

Authors:  Nicolas Bery; Gilles Favre; Aurélien Olichon
Journal:  STAR Protoc       Date:  2020-12-30

5.  Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity.

Authors:  Christine Pich; Iotefa Teiti; Guillaume Sarrabayrouse; Franck Gallardo; Rémi Gence; Anne-Françoise Tilkin-Mariamé
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.